What are the ASCO guidelines for the use of axillary lymph node dissection (ALND) in the treatment of breast cancer?

Updated: Feb 04, 2021
  • Author: Pavani Chalasani, MD, MPH; Chief Editor: John V Kiluk, MD, FACS  more...
  • Print
Answer

ASCO recommendations regarding ALND in patients who have undergone SLNB are as follows:

  • ALND is not recommended for women with early-stage breast cancer who do not have nodal metastases.

  • ALND is not recommended for women with early-stage breast cancer who have one or two sentinel lymph node metastases and will receive breast-conserving surgery with conventionally fractionated whole-breast radiotherapy.

  • ALND may be offered to women with early-stage breast cancer with nodal metastases found in SLNB specimens who will be undergoing mastectomy.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!